Bull
$7.39
シナリオ価格
$0.305
+0.016 (+5.14%)終値時点
GoHealth, Inc. is a medicare-focused digital health company that operates in a health insurance marketplace. The Company primarily offers Medicare plans, including Medicare Advantage, Medicare Supplement and prescription drug plans. Its technology platform leverages modern machine-learning algorithms, powered by insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer’s specific needs. Its Medicare Advantage offerings include Special Needs Plans (SNPs). SNPs are special kinds of Medicare Advantage plans that have benefits covering special health care or financial needs. Its Marketplace technology features decision support tools and integrates with health plan partner enterprise systems, enabling agents to quickly select the right health insurance plan for each consumer based on their specific needs and enroll them in those plans. It offers Encompass Connect and Encompass Engage services to its health plan partners.
GoHealth is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading at deeply distressed levels, the company has entered Chapter 11 restructuring, and the latest news confirms severe financial stress. Even though the price is oversold technically, the fundamental situation dominates and makes this a poor long-term purchase. Given the user's impatience and unwillingness to wait for a better entry, the clear answer is to avoid buying GOCO now.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

GoHealth Initiates Voluntary Chapter 11 Restructuring

GoHealth Inc. Files for Chapter 11 Bankruptcy Protection Amid Restructuring Efforts

GoHealth Initiates Voluntary Prepackaged Chapter 11 Process

GoHealth Reports FY Revenue of $361.8 Million

GoHealth Reports Disappointing FY Results, Shares Drop
GoHealth, Inc. is a medicare-focused digital health company that operates in a health insurance marketplace. The Company primarily offers Medicare plans, including Medicare Advantage, Medicare Supplement and prescription drug plans. Its technology platform leverages modern machine-learning algorithms, powered by insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer’s specific needs. Its Medicare Advantage offerings include Special Needs Plans (SNPs). SNPs are special kinds of Medicare Advantage plans that have benefits covering special health care or financial needs. Its Marketplace technology features decision support tools and integrates with health plan partner enterprise systems, enabling agents to quickly select the right health insurance plan for each consumer based on their specific needs and enroll them in those plans. It offers Encompass Connect and Encompass Engage services to its health plan partners. It operates in the Financials sector (INSURANCE AGENTS, BROKERS & SERVICE industry).
GoHealth is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading at deeply distressed levels, the company has entered Chapter 11 restructuring, and the latest news confirms severe financial stress. Even though the price is oversold technically, the fundamental situation dominates and makes this a poor long-term purchase. Given the user's impatience and unwillingness to wait for a better entry, the clear answer is to avoid buying GOCO now.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。